Cargando…
Isoniazid Concentration and NAT2 Genotype Predict Risk of Systemic Drug Reactions during 3HP for LTBI
Weekly rifapentine and isoniazid therapy (known as 3HP) for latent tuberculosis infection (LTBI) is increasingly used, but systemic drug reactions (SDR) remain a major concern. Methods: We prospectively recruited two LTBI cohorts who received the 3HP regimen. In the single-nucleotide polymorphism (S...
Autores principales: | Lee, Meng-Rui, Huang, Hung-Ling, Lin, Shu-Wen, Cheng, Meng-Hsuan, Lin, Ya-Ting, Chang, So-Yi, Yan, Bo-Shiun, Kuo, Ching-Hua, Lu, Po-Liang, Wang, Jann-Yuan, Chong, Inn-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616849/ https://www.ncbi.nlm.nih.gov/pubmed/31174321 http://dx.doi.org/10.3390/jcm8060812 |
Ejemplares similares
-
NAT2 Genotype and Isoniazid Medication in Children
por: Golka, Klaus, et al.
Publicado: (2016) -
The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
por: Ungcharoen, Usanee, et al.
Publicado: (2020) -
Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients
por: Toure, A., et al.
Publicado: (2016) -
Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study
por: Heyd, Amber, et al.
Publicado: (2021) -
The Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and Metabolism
por: Rogers, Zoe, et al.
Publicado: (2016)